Mackenzie Financial Corp Sorrento Therapeutics, Inc. Transaction History

Mackenzie Financial Corp

  • $66.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 07, 2022
SELL
$1.51 - $2.88 $1,224 - $2,335
-811 Reduced 3.12%
25,219 $40,000
Q2 2022

Aug 10, 2022
BUY
$1.24 - $2.33 $11,036 - $20,737
8,900 Added 51.96%
26,030 $52,000
Q1 2022

May 13, 2022
BUY
$2.0 - $4.9 $4,048 - $9,917
2,024 Added 13.4%
17,130 $40,000
Q4 2021

Feb 14, 2022
SELL
$4.65 - $7.23 $3,957 - $6,152
-851 Reduced 5.33%
15,106 $70,000
Q3 2021

Nov 08, 2021
BUY
$7.41 - $10.99 $118,241 - $175,367
15,957 New
15,957 $122,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email